UIC
SRTA

Uniplan Investment Counsel’s Strata Critical Medical Inc SRTA Stock Holding History

Uniplan Investment Counsel’s Portfolio SRTA Stock Details SRTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$5.44M Buy
1,300,317
+36,330
+3% +$175K 0.56% 48
2025
Q4 		$6.08M Sell
1,263,987
-1,862
-0.1% -$9.01K 0.61% 44
2025
Q3 		$6.41M Sell
1,265,849
-96,917
-7% -$428K 0.63% 41
2025
Q2 		$5.49M Sell
1,362,766
-365,849
-21% -$1.19M 0.56% 47
2025
Q1 		$4.72M Buy
1,728,615
+754,879
+78% +$2.71M 0.46% 56
2024
Q4 		$4.14M Sell
973,736
-68,311
-7% -$260K 0.38% 68
2024
Q3 		$3.06M Buy
1,042,047
+197,220
+23% +$628K 0.27% 85
2024
Q2 		$2.94M Sell
844,827
-662,990
-44% -$2.21M 0.27% 85
2024
Q1 		$4.3M Buy
1,507,817
+494,226
+49% +$1.52M 0.34% 65
2023
Q4 		$3.65M Buy
1,013,591
+308,497
+44% +$886K 0.27% 73
2023
Q3 		$1.85M Buy
+705,094
New +$2.48M 0.14% 107

Other funds holding SRTA

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
TP
Third Point New York $2.08B AUM 27.04% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NRCM
Northern Right Capital Management Darien, Connecticut $281M AUM 56.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AIC
AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
PLC
Pillsbury Lake Capital San Francisco, California $221M AUM
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Uniplan Investment Counsel's SRTA Position: Q1 2026 in Review

Uniplan Investment Counsel increased its Strata Critical Medical Inc (SRTA) stake by 2.9% in Q1 2026, buying an estimated $175K and bringing the position to 1,300,317 shares worth $5.44M. The position accounts for 0.56% of the portfolio, ranked #48.

Uniplan Investment Counsel first reported a position in SRTA in Q3 2023 and has held it in 11 quarters since. The position peaked at $6.41M in Q3 2025. 125 funds tracked by Wall St. Rank hold SRTA as of Q1 2026.

  • Uniplan Investment Counsel held 1,300,317 shares of Strata Critical Medical Inc worth $5.44M as of Q1 2026.
  • Uniplan Investment Counsel bought 36,330 Strata Critical Medical Inc shares in Q1 2026, an estimated $175K.
  • Strata Critical Medical Inc made up 0.56% of Uniplan Investment Counsel's portfolio in Q1 2026, its #48 holding.
  • Uniplan Investment Counsel first reported a position in Strata Critical Medical Inc in Q3 2023 and has held it in 11 quarters since.
  • Uniplan Investment Counsel's Strata Critical Medical Inc position peaked at $6.41M in Q3 2025.
  • 125 funds tracked by Wall St. Rank held Strata Critical Medical Inc as of Q1 2026.

Based on Uniplan Investment Counsel's 13F filing for Q1 2026, filed 15 May 2026.